2023年6月4日,

NewLimit——一家总部位于旧金山的公司,旨在扭转重编程细胞衰老——最近宣布,筹集了4000万美元的资金在一个首轮私募融资轮融资的维度,创始人基金和Kleiner Perkins参与埃里克•施密特(Eric Schmidt)吉尔,加里Tan和弗雷德Ehrsam。公司成立了Coinbase首席执行官布莱恩•阿姆斯特朗;风险投资家布莱克拜尔;约翰逊(机器学习);雅各Kimmel(研究)。随着一轮融资4000万美元,拜尔斯和阿姆斯特朗也在该公司投入了1.1亿美元。“NewLimit成立治愈老化。我们正在向这个目标被发现的转录因子,可以epigenetically重新编程细胞。虽然我们的产品是用来治疗衰老本身,我们也相信这些产品可以治疗或预防许多疾病与衰老有关,包括纤维化、传染性疾病、神经退行性疾病,”该公司在声明中写道。“这新资金除了奠基者最初的1.1亿美元的承诺。 With the additional capital, we plan to remain a small focused team where everyone contributes to the line work and everyone contributes to company building. There are no shortcuts… Many investors talk about funding transformative companies but few are willing to take on the risk inherent in these kinds of projects. Even though aging is the dominant driver of human disease, aging biology has been underfunded and under-explored. We believe epigenetic reprogramming is a watershed moment for aging research and we hope to spur many more groups to participate in moving this field forward. We are grateful to our investors for their belief in our team and approach. Trending on Pulse 2.0